Search results
Sanofi (SNY) Ends Development of Breast Cancer Drug, Stock Down
Zacks via Yahoo Finance· 2 years agoShares of Sanofi SNY were down 5.8% in the pre-market trading session on Aug 17, after management...
Novartis Announces Positive Data on Breast Cancer Drug Kisqali
Zacks via Yahoo Finance· 1 year agoNovartis NVS announced positive data on the breast cancer drug Kisqali (ribociclib) from the...
Sanofi Earns Price Target Cut After Stopping Breast Cancer Drug Trial
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) discontinued the development of its oral SERD amcenestrant following a...
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said it would stop further work on breast cancer drug amcenestrant, putting...
Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation
Reuters via Yahoo Finance· 1 year agoThe blood thinner Eliquis from Bristol Myers Squibb, Pfizer's breast cancer drug Ibrance and...
Sanofi trial failure halts work on breast cancer treatment amcenestrant
Reuters via Yahoo Finance· 2 years agoSanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial...
Pfizer (PFE), Arvinas Post Upbeat Data From Breast Cancer Study
Zacks via Yahoo Finance· 6 months agoInterim data from an early-stage study shows that treatment with Pfizer (PFE)/Arvinas' (ARVN) breast...
Olema Pharmaceuticals (OLMA) Skyrockets 471% YTD: Here's Why
Zacks via Yahoo Finance· 7 months agoOlema Pharmaceuticals OLMA is a clinical-stage biopharmaceutical company focused on developing...
Novartis pauses enrollment in some Kisqali trials to fix manufacturing
BioPharma Dive via Yahoo Finance· 2 months agoThe company said the pause is necessary to meet regulatory limits on nitrosamine, but added it will...
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head'
Reuters via Yahoo News· 1 year agoNEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate drug...